TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer characterized by poor prognosis and limited treatment options, often associated with significant toxicity. Recently, we described TG6002, an oncolytic vaccinia virus (VACV) engineered for tumor-selective replication through the del...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-09-01
|
| シリーズ: | Frontiers in Microbiology |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1656984/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|